<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02326714</url>
  </required_header>
  <id_info>
    <org_study_id>AA for PCOS</org_study_id>
    <nct_id>NCT02326714</nct_id>
  </id_info>
  <brief_title>Auricular Acupressure (AA) For Overweight/Obese Adolescent and Young Polycystic Ovary Syndrome ( PCOS)</brief_title>
  <official_title>Effect of Auricular Acupressure on Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heilongjiang University of Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heilongjiang University of Chinese Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to investigate the effect and safety of auricular acupressure on
      adolescent and young women with PCOS. Subjects will be randomly assigned in to two arms:
      Auricular acupressure arm and placebo auricular acupressure, both arms will be treated for
      three months. Body mass index, oral glucose tolerance test, hormonal profile and metabolic
      profile will be determined.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body mass index (BMI): BMI change at 3 months.</measure>
    <time_frame>3 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral glucose tolerance test (OGTT)</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Testosterone (T)</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sex hormone-binding globulin (SHBG)</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dehydroepiandrosterone sulfate (DHEAS).</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follicle stimulating hormone (FSH)</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Luteinizing hormone (LH)</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides (TG)</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist/hip ratio</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ferriman-Gallwey score</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>Auricular acupressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The magnetic beads will be taped to the seven pressing points: Hunger point, Ovary, Uterus, Endocrine point, liver, kidney and spleen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo auricular acupressure</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The magnetic beads will be taped to the three pressing points:Tonsil, eye and elbow.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Auricular acupressure</intervention_name>
    <description>The magnetic beads were taped to the auricular acupressure points, by the same acupuncture specialist on one ear approximately after skin sterilization, and the subjects were asked to massage the points for 5 minutes, 30 minutes before three meals and sleep.The magnetic beads were left in situ, but replaced with new ones once every week in the other ear.</description>
    <arm_group_label>Auricular acupressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo auricular acupressure</intervention_name>
    <description>The magnetic beads were taped to the auricular acupressure points, by the same acupuncture specialist on one ear approximately after skin sterilization, and the subjects were not asked to massage the points.The magnetic beads were left in situ, but replaced with new ones once every week in the other ear.</description>
    <arm_group_label>Placebo auricular acupressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women aged between 12 and 25 years.

          -  Diagnosis of PCOS according to the modified Rotterdam criteria.

          -  2 years after menarche.

          -  Body mass index (BMI) equal to or greater than 23 kg/m*m.

        Exclusion Criteria:

          -  Administration of other medications known to affect reproductive function or
             metabolism within the past three months, including oral contraceptives,
             Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens,
             gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such
             as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel
             blockers.

          -  Patients with other endocrine disorders including 21-hydroxylase deficiency,
             hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome.

          -  Patients with known severe organ dysfunction or mental illness.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lihui Hou, Bachelor</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital of Heilongjiang University Of Chinese</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan Li, Doctor</last_name>
    <phone>+86-451-82111401</phone>
    <email>liyantcm@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>First Affiliated Hospital, Heilongjiang University of Chinese Medicine</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lihui Hou, Bachelor</last_name>
      <phone>86-451-82111401</phone>
      <email>houlihui2007@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2014</study_first_submitted>
  <study_first_submitted_qc>December 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2014</study_first_posted>
  <last_update_submitted>December 18, 2017</last_update_submitted>
  <last_update_submitted_qc>December 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heilongjiang University of Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Yan Li</investigator_full_name>
    <investigator_title>Associate chief physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

